share_log

Chardan Capital Maintains Buy on Senti Biosciences, Raises Price Target to $12

Chardan Capital Maintains Buy on Senti Biosciences, Raises Price Target to $12

Chardan Capital维持对Senti Biosciences的买入评级,将价格目标上调至12美元
Benzinga ·  12/04 20:21

Chardan Capital analyst Geulah Livshits maintains Senti Biosciences (NASDAQ:SNTI) with a Buy and raises the price target from $10 to $12.

Chardan Capital分析师Geulah Livshits维持对Senti Biosciences(纳斯达克:SNTI)的买入评级,并将价格目标从10美元上调至12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发